New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Overview of attention for article published in Journal of Neuroinflammation, June 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 56 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 13,782 followers.

New insights into the pharmacokinetics & pharmacodynamics of natalizumab treatment for MSers https://t.co/thBb7qpd2s

Reply Repost Favourite

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple… https://t.co/vWnBXk4Lho

Reply Repost Favourite

RT @TZiemssen: https://t.co/O2r5tN1AIn

Reply Repost Favourite

https://t.co/O2r5tN1AIn

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.